HIV Antiretroviral Drug Resistance: What's new in Mali? What is the future?

HIV Antiretroviral Drug Resistance: What's new in Mali? What is the future?

La résistance aux antirétroviraux prend une grande ampleur avec la disponibilité de plus en plus des de ces traitements au Mali, surtout dans un contexte où les laboratoires ont des capacités limitées à offrir des outils virologiques pour un suivi optimal.

Bibliographic Details
Main Authors:	Almoustapha Maiga, et al
Format:	Article
Language:	fra
Published:	SOMAPIT 2016-02-01
Series:	Revue Malienne d’Infectiologie et de Microbiologie
Online Access:	https://www.revues.ml/index.php/remim/article/view/938

Similar Items

Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?
by: Aliou Baldé, et al.
Published: (2020-01-01)

Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?
by: Aliou Baldé, et al.
Published: (2020-01-01)

Antiretroviral induced adverse drug reactions in HIV infected patients in Mali: A resource-limited setting
by: A.A. Oumar, et al.
Published: (2014-04-01)

What's new for antiretroviral treatment in women with HIV
by: Nisha Andany, et al.
Published: (2016-04-01)

Novel Approaches for the Delivery of Anti-HIV Drugs—What Is New?
by: José das Neves
Published: (2019-10-01)

Current Perspectives on HIV-1 Antiretroviral Drug Resistance
by: Pinar Iyidogan, et al.
Published: (2014-10-01)

What's New and Plans for the Future
by: Sebastian Faro
Published: (1999-01-01)

Extensively drug resistant tuberculosis in Mali: a case report
by: Bassirou Diarra, et al.
Published: (2017-11-01)

HIV drug resistance and antiretroviral therapy programs in Henan, China
by: Zhi-Bin Liu, et al.
Published: (2020-02-01)

Population dynamics in HIV-1 transmitted antiretroviral drug resistance
by: Harris, Dean Mark
Published: (2018)

Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in Mali
by: Aude Jary, et al.
Published: (2019-12-01)

Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?
by: Cazzaniga ME, et al.
Published: (2019-04-01)

HIV genomics : trends in antiretroviral resistance and future directions for pharmacogenetic testing
by: Rocheleau, Genevieve
Published: (2017)

Pan-resistant HIV-1: what's next?
by: Raph L Hamers, et al.
Published: (2020-07-01)

What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
by: Surendra K Sharma, et al.
Published: (2019-01-01)

HIV drug resistance and its impact on antiretroviral therapy in Chinese HIV-infected patients.
by: Hui Xing, et al.
Published: (2013-01-01)

Transmitted antiretroviral drug resistance in a low HIV prevalence setting
by: Nguyen, Thuy Thi Vu
Published: (2012)

Analysis of the frequency of formation of HIV mutations associated with resistance to antiretroviral drugs
by: M.G. Liulchuk, et al.
Published: (2020-09-01)

Injectable Antiretroviral Drugs: Back to the Future
by: Marco Berruti, et al.
Published: (2021-02-01)

Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future
by: Marianne Harris, et al.
Published: (2012-01-01)

CELLULAR RESISTANCE TO THE ANTIRETROVIRAL DRUGS
by: G. Antonelli
Published: (2004-06-01)

Antiretroviral drug resistance testing
by: Sen Sourav, et al.
Published: (2006-01-01)

Besnoitiosis in caribou: What we know and what we don't know
by: Julie Ducrocq et al.
Published: (2011-09-01)

HIV drug resistance in HIV positive individuals under antiretroviral treatment in Shandong Province, China.
by: Bin Lin, et al.
Published: (2017-01-01)

Five Antiretroviral Drug Class–Resistant HIV-1 in a Treatment-Naïve Patient Successfully Suppressed with Optimized Antiretroviral Drug Selection
by: Joseph M. Volpe PhD, et al.
Published: (2015-09-01)

Tuberculosis, before and after Antiretroviral Therapy among HIV-Infected Children in Nigeria: What Are the Risk Factors?
by: Emmanuel A Anígilájé, et al.
Published: (2016-01-01)

Antiretroviral drug use and HIV drug resistance in female sex workers in Tanzania and the Dominican Republic.
by: Wendy Grant-McAuley, et al.
Published: (2020-01-01)

Pretreatment HIV drug resistance in adults initiating antiretroviral therapy in China, 2017
by: Rui-Hua Kang, et al.
Published: (2020-05-01)

HIV drug resistance and antiretroviral therapy programs in Henan, China-authors’ reply
by: Lulu Zuo, et al.
Published: (2020-02-01)

Białowieża Forest: what it used to be, what it is now and what we want it to be in the future
by: Szwagrzyk Jerzy
Published: (2016-12-01)

What’s new about resistant hypertension?
by: Fernando Antonio de Almeida
Published: (2018-12-01)

New Drug Treatments for Osteoarthritis: What is on the Horizon
by: Fiona E. Watt, et al.
Published: (2017-03-01)

ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG?
by: I. V. Zhirov
Published: (2015-12-01)

ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG?
by: I. V. Zhirov
Published: (2015-12-01)

Drug- Resistance- Associated Mutations and HIV Sub-Type Determination in Drug-Naïve and HIV-Positive Patients under Treatment with Antiretroviral Drugs
by: H Naziri, et al.
Published: (2013-10-01)

Scaling up the use of antiretrovirals in the public sector: What are the challenges?
by: Helen Schneider, et al.
Published: (2003-07-01)

HIV Drug Resistance-Associated Mutations in Antiretroviral Naïve HIV-1-Infected Latin American Children
by: Luis E. Soto-Ramirez, et al.
Published: (2010-01-01)

Incidence and associated factors of HIV drug resistance in Chinese HIV-infected patients receiving antiretroviral treatment.
by: Hui Xing, et al.
Published: (2013-01-01)

Connaissances, attitudes et pratiques face aux IST VIH-SIDA chez les lycéens de Gao (Nord-Mali Afrique de l’Ouest).
by: Y Cissoko, et al.
Published: (2014-11-01)

Epidemiology and Evolution of Antiretroviral Drug Resistance
by: Wainberg Mark A
Published: (2005-12-01)